Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
) pushed the Wholesale industry higher today making it today's featured wholesale winner. The industry as a whole closed the day down 0.2%. By the end of trading, Omnicare rose $0.68 (1.5%) to $46.09 on average volume. Throughout the day, 1,167,932 shares of Omnicare exchanged hands as compared to its average daily volume of 1,098,800 shares. The stock ranged in a price between $45.05-$46.11 after having opened the day at $45.16 as compared to the previous trading day's close of $45.41. Other companies within the Wholesale industry that increased today were:
), up 4.8%,
), up 2.7%,
), up 2.0% and
), up 1.5%.
- EXCLUSIVE OFFER: Jim Cramer's Protege, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. The company operates in two segments, Long-Term Care Group and Specialty Care Group. Omnicare has a market cap of $4.8 billion and is part of the services sector. The company has a P/E ratio of 26.0, above the S&P 500 P/E ratio of 17.7. Shares are up 25.8% year to date as of the close of trading on Thursday. Currently there are 4 analysts that rate Omnicare a buy, no analysts rate it a sell, and 2 rate it a hold.
TheStreet Ratings rates Omnicare as a
. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Omnicare Ratings Report.
On the negative front,
), down 6.6%,
), down 3.9%,
), down 3.4% and
), down 2.6% , were all laggards within the wholesale industry with
) being today's wholesale industry laggard.
- Use our wholesale section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the wholesale industry could consider
) while those bearish on the wholesale industry could consider
- Find other investment ideas from our top rated ETFs lists.
Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100%. See his top picks for 14-days FREE.